Stopped trading. Last price we have: $90.00 on Dec 30, 2025. Fund positions aren't valued until we confirm what happened.

MERUS N V
MRUS (MERUS N V) is held by 3 institutional investors as of Q4 2025. Top institutional shareholders: XTX Topco Ltd ($2.4M), Farther Finance Advisors, LLC ($90,900), Simplex Trading, LLC ($75,330).
No verdict yet — fewer than 2 funds hold MRUS.
Top Holders
Showing 1-20 of 130
| Insider | Trade | Traded |
|---|---|---|
| GENMAB A/S | Buy $102.1M | |
| GENMAB A/S | Buy $7359.1M | |
| GENMAB A/S | Buy $289K | |
| GENMAB A/S | Buy $13.8M | |
| GENMAB A/S | Buy $9.3M | |
| GENMAB A/S | Buy $54.4M | |
| GENMAB A/S | Buy $1.5M | |
| GENMAB A/S | Buy $6.4M | |
| GENMAB A/S | Buy $20.6M | |
| GENMAB A/S | Buy $14.6M |
| Filer | Stake | Filed |
|---|---|---|
| Paradigm BioCapital Advisors LP | 0.0% | |
| Genmab A/S | 0.0% | |
| RTW Investments, LP | 2.7% | |
| Wellington Management Group LLP | 0.6% | |
| FMR LLC | 3.7% | |
| Commodore Capital LP | 4.7% |
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about MRUS
Who owns MRUS?
3 institutional investors held MRUS on December 31, 2025, led by XTX Topco Ltd ($2.4M), Farther Finance Advisors, LLC ($90,900) and Simplex Trading, LLC ($75,330).
How many hedge funds hold MRUS?
3 institutional investors reported MRUS in their 13F filings for the quarter ended December 31, 2025, $2.6M in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer